Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
Express Scripts
Medtronic
Johnson and Johnson

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Biologic Drugs With Established Pharmaceutical Class: Programmed Death Receptor-1 Blocking Antibody

➤ Subscribe for complete access

« Back to Dashboard

Biologic Drugs With Established Pharmaceutical Class: Programmed Death Receptor-1 Blocking Antibody

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Merck Sharp & Dohme Corp. KEYTRUDA pembrolizumab For Injection 125514 2014-09-04 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Bristol-myers Squibb Company OPDIVO nivolumab Injection 125554 2014-12-22 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Genentech, Inc. TECENTRIQ atezolizumab Injection 761034 2016-05-18 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Glaxosmithkline Llc JEMPERLI dostarlimab-gxly Injection 761174 2021-04-22 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
McKesson
McKinsey
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.